Shanxi Zhendong Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanxi Zhendong Pharmaceutical Co Ltd with three other
companies in this sector in China:
ChangChun High New Technology Industries
sales of 2.87 billion Chinese Renmimbi [US$417.11 million]
of which 81%
Hunan ER-KANG Pharmaceutical Co Ltd
(2.96 billion Chinese Renmimbi [US$429.74 million]
of which 92%
was Manufacture of Medicines), and
Shandong Xinhua Pharmaceutical Company Limited
(4.01 billion Chinese Renmimbi [US$582.72 million]
of which 44%
was Chemical Raw Medicine).
During the year ended December of 2016, sales at
Shanxi Zhendong Pharmaceutical Co Ltd were 3.28 billion Chinese Renmimbi (US$476.36 million).
increase of 45.1%
versus 2015, when the company's sales were 2.26 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shanxi Zhendong Pharmaceutical Co Ltd
(and since 2011, sales have increased a total of 156%).
Sales of Medicinal Curb Planting saw an increase
71.0% in 2016, from
104.73 million Chinese Renmimbi to 179.07 million Chinese Renmimbi.
Not all segments of Shanxi Zhendong Pharmaceutical Co Ltd experienced an increase in sales in 2016:
sales of Other fell 23.4% to 11.20 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).